These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21475235)

  • 1. A Src link in schizophrenia.
    Hahn CG
    Nat Med; 2011 Apr; 17(4):425-7. PubMed ID: 21475235
    [No Abstract]   [Full Text] [Related]  

  • 2. Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors.
    Pitcher GM; Kalia LV; Ng D; Goodfellow NM; Yee KT; Lambe EK; Salter MW
    Nat Med; 2011 Apr; 17(4):470-8. PubMed ID: 21441918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model of neuregulin control of NMDA receptors on synaptic spines.
    Bennett MR; Farnell L; Gibson WG
    Bull Math Biol; 2012 Mar; 74(3):717-35. PubMed ID: 22147103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding a druggable target for schizophrenia.
    Rico B
    Proc Natl Acad Sci U S A; 2012 Jul; 109(30):11902-3. PubMed ID: 22778429
    [No Abstract]   [Full Text] [Related]  

  • 5. Dysregulated Src upregulation of NMDA receptor activity: a common link in chronic pain and schizophrenia.
    Salter MW; Pitcher GM
    FEBS J; 2012 Jan; 279(1):2-11. PubMed ID: 21985289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased NRG1-ErbB4 signaling in human symptomatic epilepsy.
    Zhu JM; Li KX; Cao SX; Chen XJ; Shen CJ; Zhang Y; Geng HY; Chen BQ; Lian H; Zhang JM; Li XM
    Sci Rep; 2017 Mar; 7(1):141. PubMed ID: 28273943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression.
    Bennett M
    Aust N Z J Psychiatry; 2009 Aug; 43(8):711-21. PubMed ID: 19629792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy.
    Law AJ; Wang Y; Sei Y; O'Donnell P; Piantadosi P; Papaleo F; Straub RE; Huang W; Thomas CJ; Vakkalanka R; Besterman AD; Lipska BK; Hyde TM; Harrison PJ; Kleinman JE; Weinberger DR
    Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12165-70. PubMed ID: 22689948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuropsin signaling as a novel therapeutic target of schizophrenia].
    Tawara-Hirata Y
    Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):153-5. PubMed ID: 24614639
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia.
    Mei L; Xiong WC
    Nat Rev Neurosci; 2008 Jun; 9(6):437-52. PubMed ID: 18478032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressions of neuregulin 1beta and ErbB4 in prefrontal cortex and hippocampus of a rat schizophrenia model induced by chronic MK-801 administration.
    Feng Y; Wang XD; Guo CM; Yang Y; Li JT; Su YA; Si TM
    J Biomed Biotechnol; 2010; 2010():859516. PubMed ID: 20467458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases.
    Olayioye MA; Beuvink I; Horsch K; Daly JM; Hynes NE
    J Biol Chem; 1999 Jun; 274(24):17209-18. PubMed ID: 10358079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice.
    Bjarnadottir M; Misner DL; Haverfield-Gross S; Bruun S; Helgason VG; Stefansson H; Sigmundsson A; Firth DR; Nielsen B; Stefansdottir R; Novak TJ; Stefansson K; Gurney ME; Andresson T
    J Neurosci; 2007 Apr; 27(17):4519-29. PubMed ID: 17460065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice.
    Savonenko AV; Melnikova T; Laird FM; Stewart KA; Price DL; Wong PC
    Proc Natl Acad Sci U S A; 2008 Apr; 105(14):5585-90. PubMed ID: 18385378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src kinases: a hub for NMDA receptor regulation.
    Salter MW; Kalia LV
    Nat Rev Neurosci; 2004 Apr; 5(4):317-28. PubMed ID: 15034556
    [No Abstract]   [Full Text] [Related]  

  • 16. N-methyl-D-aspartate receptors mediate diphosphorylation of extracellular signal-regulated kinases through Src family tyrosine kinases and Ca2+/calmodulin-dependent protein kinase II in rat hippocampus after cerebral ischemia.
    Wu HW; Li HF; Guo J
    Neurosci Bull; 2007 Mar; 23(2):107-12. PubMed ID: 17592533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling.
    Fazzari P; Paternain AV; Valiente M; Pla R; Luján R; Lloyd K; Lerma J; Marín O; Rico B
    Nature; 2010 Apr; 464(7293):1376-80. PubMed ID: 20393464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tyrosine phosphatase Shp2 (PTPN11) directs Neuregulin-1/ErbB signaling throughout Schwann cell development.
    Grossmann KS; Wende H; Paul FE; Cheret C; Garratt AN; Zurborg S; Feinberg K; Besser D; Schulz H; Peles E; Selbach M; Birchmeier W; Birchmeier C
    Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16704-9. PubMed ID: 19805360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uniting the neurodevelopmental and immunological hypotheses: Neuregulin 1 receptor ErbB and Toll-like receptor activation in first-episode schizophrenia.
    Kéri S; Szabó C; Kelemen O
    Sci Rep; 2017 Jun; 7(1):4147. PubMed ID: 28646138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of genes involved in neuroplasticity and neurogenesis in the observation of a gene-environment interaction (GxE) in schizophrenia.
    Le Strat Y; Ramoz N; Gorwood P
    Curr Mol Med; 2009 May; 9(4):506-18. PubMed ID: 19519407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.